Paul Peter Tak

CADL

Paul Peter Tak serves as director, officer: Chief Executive Officer at Candel Therapeutics, Inc. (CADL). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

2 trades

$230.0K

Total Sells

8 trades

$4.25M

Net Position

Net Seller

$4.02M

Companies Traded

CADL

Active Period

Jul 2021 – Sep 2026

10 total trades

Most Recent

Sell CADL

Sep 11, 2026 · $3.16M

Paul Peter Tak's Insider Trading at Candel Therapeutics, Inc. (CADL)

Buys

2 · $230.0K

Sells

8 · $4.25M

Total Shares Bought

40,985

Total Shares Sold

484,404

CADL Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Sep 11, 2026	Sell	280,245	$11.28	$3.16M	172,700
Mar 18, 2025	Sell	26,172	$8.77	$229.6K	0
Jan 15, 2025	Sell	21,704	$7.22	$156.8K	0
Jan 8, 2025	Sell	21,172	$8.22	$174.0K	0
Nov 29, 2024	Sell	48,847	$4.56	$222.5K	0
Jul 17, 2024	Sell	22,528	$6.47	$145.8K	0
Jul 11, 2024	Sell	20,293	$5.97	$121.2K	0
Nov 28, 2023	Sell	43,443	$0.90	$39.1K	0
Dec 8, 2022	Buy	15,985	$1.88	$30.0K	0
Jul 29, 2021	Buy	25,000	$8.00	$200.0K	0

Related Insiders

Seshu Tyagarajan

officer: Chief Technology Officer

CADLSell · Aug 19, 2026

Francesca Barone

officer: Chief Scientific Officer

CADLSell · Jul 1, 2026

Paul B Manning

director

CADLBuy · Feb 26, 2026

Explore More Insider Trading Data

CADL Insider Trading Activity

View all insider trades at Candel Therapeutics, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity